Therefore, these results suggest that HLA-E expression at the surface of ΔTRACCARΔB2MHLAE T cells is likely to inhibit NK cells from most ALL and AML patients, regardless of the stage of their disease. This evidence concerns the gene HLA-E and acute myeloid leukemia.